|Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 581 active entries
104 35 Stockholm
Phone: +46 8 524 868 72
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Evitra is a Swedish biotech company that offers a solution to the problem of obtaining soluble protein expression also for mammalian proteins in Escherichia coli. Evitra launches the SPOTLIGHT system that constitutes a major technological breakthrough and enables soluble protein production within weeks at dramatically improved success rates. Evitra offers SPOTLIGHT either as a service or as a technology transfer license agreement to pharmaceutical and biotech companies.
Last update of this entry: October 08, 2012